Prevention & lipids

Lipoprotein(a) Levels in Disaggregated Racial and Ethnic Subgroups Across Atherosclerotic Cardiovascular Disease Risk Levels

JACC AdvPublished Retrospective cohort study

Authors' conclusion

Of those tested, Lp(a) levels were frequently elevated and differed significantly across disaggregated race and ethnicity groups. The prevalence of elevated Lp(a) increased with increasing ASCVD risk, with significant variation by race and ethnicity.

Study context

Population
Adults (≥18 years) with ≥2 primary care visits and complete race and ethnicity data who underwent Lp(a) testing, large California health care system, 2010–20210.9% underwent Lp(a) testing
Participants
13,689 adults
Exposure
Elevated Lp by disaggregated race, ethnicity and atherosclerotic cardiovascular disease (ASCVD) risk
Outcome
Elevated Lp(a) (≥50 mg/dL)

Main finding

As reported in the abstract

Each group vs NH WhiteOdds ratio (95% CI)
Hispanicadjusted; lower odds
0.76(0.66–0.88)
Asianadjusted; lower odds
0.88(0.81–0.96)
Blackadjusted; higher odds
2.46(1.97–3.07)

Observational data: associations, not effects.

Further findings

OutcomeNH WhiteNH-BlackHispanicNH-Asian
ASCVD risk of those tested, by race
Established ASCVDNot reported in the abstract27.2%Not reported in the abstractNot reported in the abstractNH White, Hispanic, NH-Asian: not reported in the abstract
  • ASCVD risk of those tested, by race: Asian Indian 73.6% · <5% 10-year risk 73.6%

Elevated Lp(a) across ASCVD risk spectrum

Prevalence of Lp(a) ≥50 mg/dL increased across the ASCVD risk spectrum

Original publication

Lipoprotein(a) Levels in Disaggregated Racial and Ethnic Subgroups Across Atherosclerotic Cardiovascular Disease Risk Levels. JACC Adv. Published 2 May 2024. doi:10.1016/j.jacadv.2024.100940

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.